Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | PTGER4 | P35408 | 6/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28605584 | 1.00 | MAPT (0.62) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL31247978 | 0.93 | TP53 (0.63) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL28610296 | 0.91 | PTGER4 (0.67) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL28600078 | 0.87 | DRD2 (0.69) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL31472964 | 0.86 | MAPT (0.65) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL28608855 | 0.86 | MAPT (0.65) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL9663682 | 0.85 | PTGER4 (0.62) | KDM4ETSHRALDH1A1GAALMNA | |
| SCHEMBL28609161 | 0.84 | HDAC1 (0.57) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL14785734 | 0.83 | MAPT (0.82) | MAPTKDM4ETSHRALDH1A1GAA | |
| SCHEMBL28597103 | 0.81 | DRD2 (0.66) | KDM4ETSHRALDH1A1GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12098134-B2 | Benzo-heterocyclic compound and composition for preventing or treating cancer disease, containing same as active ingredient | INDUSTRY ACADEMIC COOPERATION FOUNDATION KEIMYUNG UNIVERSITY (KR) | 2024-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12098134-B2 | Benzo-heterocyclic compound and composition for preventing or treating cancer disease, containing same as active ingredient | VHL, BRCA1, BRD1 | MAPT 2805/4885KDM4E 794/4885TSHR 4493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.